MedTrace Logo

Effects of a Therapy With INTRAVIT® Tablets in Patients With Diabetic Retinopathy

NCT04742829 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-02-08

No results posted yet for this study

Summary

Evaluation of the effect of a therapy with INTRAVIT® tablets, on retinal edema considering also the central retinal sensitivity (Microperimetry) and the visual acuity in course of diabetic retinopathy.

Conditions

Interventions

DIETARY_SUPPLEMENT

INTRAVIT ®

2 tablets per day morning and evening before meals

Sponsors & Collaborators

  • University of Molise

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-03-08
Completion
2021-03-08

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04742829 on ClinicalTrials.gov